1-3 of 3
Emma L. Davenport, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of HDACs and Aminopeptidases Is Highly Synergistic in Myeloma Cells Resulting in Cell Death Via the Upregulation of BIRC3, a Key Mediator of NF-KappaB Signalling.

Emma M Smith, PhD, Brian A Walker, PhD, Emma L Davenport, PhD, Lauren I Aronson, BSc.Hons., David Krige, PhD, Leon Hooftman, MD, Alan Drummond, PhD, Gareth J Morgan, MD, PhD, Faith Davies, MD
Journal: Blood
Blood (2009) 114 (22): 607.
https://doi.org/10.1182/blood.V114.22.607.607
Published: 2009
Journal Articles

Aminopeptidase Inhibition as a Targeted Treatment Strategy in Myeloma.

Faith E. Davies, MD, Hannah E. Moore, Emma L. Davenport, PhD, Alan S. Dunlop, Srikanth Muralikrishnan, David Krige, PhD, Leon Hooftman, MD, Gareth Morgan, PhD
Journal: Blood
Blood (2007) 110 (11): 2505.
https://doi.org/10.1182/blood.V110.11.2505.2505
Published: 2007
Journal Articles

Hsp90 Inhibitors Deliver a Death Signal Via the Endoplasmic Reticulum Stress Pathway in Myeloma.

Emma L. Davenport, PhD, Hannah Moore, BSc, Alan Dunlop, BSc, Paul Workman, PhD, Gareth J. Morgan, MD, PhD, Faith E. Davies, MD
Journal: Blood
Blood (2006) 108 (11): 848.
https://doi.org/10.1182/blood.V108.11.848.848
Published: 2006